TY - JOUR
T1 - Ultrashort pulsed laser treatment inactivates viruses by inhibiting viral replication and transcription in the host nucleus
AU - Tsen, Shaw Wei D
AU - Chapa, Travis
AU - Beatty, Wandy
AU - Xu, Baogang
AU - Tsen, Kong-Thon
AU - Achilefu, Samuel
N1 - Funding Information: This work was supported in part by the Mallinckrodt Institute of Radiology Development Fund , NIH grants R01 EB008111 , R33 CA123537 (SA), and National Heart, Lung, and Blood Institute Ruth L. Kirschstein NRSA F30 grant HL116183-01 (SDT).
PY - 2014/10
Y1 - 2014/10
N2 - Ultrashort pulsed laser irradiation is a new method for virus reduction in pharmaceuticals and blood products. Current evidence suggests that ultrashort pulsed laser irradiation inactivates viruses through an impulsive stimulated Raman scattering process, resulting in aggregation of viral capsid proteins. However, the specific functional defect(s) in viruses inactivated in this manner have not been demonstrated. This information is critical for the optimization and the extension of this treatment platform to other applications. Toward this goal, we investigated whether viral internalization, replication, or gene expression in cells were altered by ultrashort pulsed laser irradiation. Murine Cytomegalovirus (MCMV), an enveloped DNA virus, was used as a model virus. Using electron and fluorescence microscopy, we found that laser-treated MCMV virions successfully internalized in cells, as evidenced by the detection of intracellular virions, which was confirmed by the detection of intracellular viral DNA via PCR. Although the viral DNA itself remained polymerase-amplifiable after laser treatment, no viral replication or gene expression was observed in cells infected with laser-treated virus. These results, along with evidence from previous studies, support a model whereby the laser treatment stabilizes the capsid, which inhibits capsid uncoating within cells. By targeting the mechanical properties of viral capsids, ultrashort pulsed laser treatment represents a unique potential strategy to overcome viral mutational escape, with implications for combatting emerging or drug-resistant pathogens.
AB - Ultrashort pulsed laser irradiation is a new method for virus reduction in pharmaceuticals and blood products. Current evidence suggests that ultrashort pulsed laser irradiation inactivates viruses through an impulsive stimulated Raman scattering process, resulting in aggregation of viral capsid proteins. However, the specific functional defect(s) in viruses inactivated in this manner have not been demonstrated. This information is critical for the optimization and the extension of this treatment platform to other applications. Toward this goal, we investigated whether viral internalization, replication, or gene expression in cells were altered by ultrashort pulsed laser irradiation. Murine Cytomegalovirus (MCMV), an enveloped DNA virus, was used as a model virus. Using electron and fluorescence microscopy, we found that laser-treated MCMV virions successfully internalized in cells, as evidenced by the detection of intracellular virions, which was confirmed by the detection of intracellular viral DNA via PCR. Although the viral DNA itself remained polymerase-amplifiable after laser treatment, no viral replication or gene expression was observed in cells infected with laser-treated virus. These results, along with evidence from previous studies, support a model whereby the laser treatment stabilizes the capsid, which inhibits capsid uncoating within cells. By targeting the mechanical properties of viral capsids, ultrashort pulsed laser treatment represents a unique potential strategy to overcome viral mutational escape, with implications for combatting emerging or drug-resistant pathogens.
KW - Murine cytomegalovirus
KW - Pathogen inactivation
KW - Pathogen reduction
KW - Ultrashort pulsed lasers
UR - http://www.scopus.com/inward/record.url?scp=84906968863&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906968863&partnerID=8YFLogxK
U2 - 10.1016/j.antiviral.2014.07.012
DO - 10.1016/j.antiviral.2014.07.012
M3 - Article
C2 - 25086212
SN - 0166-3542
VL - 110
SP - 70
EP - 76
JO - Antiviral Research
JF - Antiviral Research
ER -